The hemodynamics of cirrhosis and the development of hepatorenal syndrome

Liver Transplantation

Volumn 12, Issue 1, 2006, Pages 162-

  Perkins, James ^a  

^a UNIVERSITY OF WASHINGTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; NORADRENALIN; RENIN; APROTININ; HEMOSTATIC AGENT; SERINE PROTEINASE INHIBITOR;

ARTERY DILATATION; ARTICLE; ASCITES; CONCENTRATION (PARAMETERS); DISEASE SEVERITY; FOLLOW UP; HEART OUTPUT; HEPATORENAL SYNDROME; HUMAN; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LIVER VEIN; LUNG WEDGE PRESSURE; MEAN ARTERIAL PRESSURE; PATHOPHYSIOLOGY; PREDICTION; PRESSURE GRADIENT; PRIORITY JOURNAL; VASCULAR RESISTANCE; VENOUS PRESSURE; HEART SURGERY; LIVER TRANSPLANTATION; RISK FACTOR;

CARDIAC OUTPUT, LOW; FEMALE; HEMODYNAMIC PROCESSES; HEPATORENAL SYNDROME; HUMANS; INCIDENCE; KIDNEY FUNCTION TESTS; LIVER CIRRHOSIS; LIVER FUNCTION TESTS; MALE; PROGNOSIS; PULMONARY WEDGE PRESSURE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SURVIVAL RATE; APROTININ; CARDIAC SURGICAL PROCEDURES; HEMOSTATICS; LIVER TRANSPLANTATION; RISK FACTORS; SERINE PROTEINASE INHIBITORS;

EID: 33645107281     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.20866     Document Type: Article

References (3)

1. Ginès P, Cárdenas A, Arroyo V, Rodés J. Management of cirrhosis and ascites. N Engl J Med 2004;350:1646-1654.
2. Campbell, MS, Kotlyar DS, Brensinger CM, Lewis JD, Shetty K, Bloom RD et al. Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation. Liver Transpl 2005;11:1048-1055.
3. Møller S, Bendtsen F, Henriksen JH. Pathophysiological basis of pharmacotherapy in the hepatorenal syndrome. Scand J Gastroenterol 2005;40:491-500.